Efficacy and toxicities of a reduced dose sunitinib regimen in metastatic renal cell carcinoma
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
868 abstracts found.
Results filter
- Year: 2009 Remove Filter
Biological properties of the novel Chk1 inhibitor SAR-020106
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1The Institute of Cancer Research, Surrey, UK, 2Sareum Ltd, Cambridge, UK
Combined targeting of Aurora B (AZD1152) and MEK1/2 (AZD6244) kinases leads to enhancement of anti-tumour effects in vivo
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1AstraZeneca Pharmaceuticals, Macclesfield, UK, 2The Institute of Cancer Research, Sutton, UK
Phase I evaluation of radioimmunotherapy with 131I-CHT25 in patients with refractory IL2-receptor-expressing lymphomas
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Cancer Research UK, London, UK, 2Royal Free Hospital, London, UK
Construction and characterisation of novel fusion toxin targeted to cancer (DT-SCF)
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
Indian Institute of Technology Madras, Tamil Nadu, India
Life-long vegetarianism and risk of colorectal cancer in India: a case-control study
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Oxford University, UK, 2Tata Memorial Centre, Mumbai, India
Array comparative genomic hybridisation analysis of colorectal cancer shows prognostically relevant differential patterns of DNA copy number alterations in microsatellite stable and unstable tumours
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Cambridge, UK, 2University of Hong Kong, Hong Kong, 3University of Edinburgh, UK
Aspirin, non-steroidal anti-inflammatory drug and paracetamol use is associated with an increased risk of prostate cancer in a large, population-based, case-control study
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Bristol, UK, 2John Radcliffe Hospital, Oxford, UK, 3University of Cambridge, UK
Lifestyle intervention improves functional capacity in men on androgen deprivation therapy for prostate cancer
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Sheffield Hallam University, UK, 2University of Sheffield, UK, 3University of Birmingham, UK
Investigating the link between diet and prostate cancer within the ProtecT trial
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Bristol, UK, 2Cambridge University Addenbrookes Hospital, UK, 3University of Oxford, UK, 4University of York, UK
A comparison of the UCLA Integrated Staging System (UISS) model and the Leibovich score in survival prediction for patients with non-metastatic clear cell renal cell carcinoma
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1The National Cancer Centre, Singapore, 2Singapore General Hospital, Singapore
A neurofuzzy model to identify insignificant prostate cancer: development and validation using the ProtecT randomised controlled trial
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Sheffield, UK, 2University of Oxford, UK, 3University of Cambridge, UK, 4University of Bristol, UK, 5Brunel University, London, UK
A comparison of MicroRNA profiles in the circulating cells from men with locally confined and advanced prostate cancer
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Sheffield, UK, 2University of Oxford, UK
Recognition of anxiety and depression in gynaecological cancer using the HAD Score
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Christie Hospital NHS Foundation Trust, Manchester, UK, 2Manchester Royal Infirmary, UK
Needle oophropexy: a new simple technique for ovarian transposition prior to pelvic irradiation
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
National Cancer Institute, Cairo University, Egypt
Radiotherapy-related heart damage in breast cancer patients is predicted by cutaneous telangiectasiae
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Leicester, UK, 2University Hospitals of Leicester, Glenfield Hospital, UK, 3Nottingham University Hospitals NHS Trust, UK
A study of the relationship between drug efficacy/toxicity and platinum-DNA adduct formation in pre- and post-infusion lymphocyte samples from patients receiving platinum-based chemotherapy
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Leicester, UK, 2Loughborough University, UK
Gemcitabine with or without prophylactic weight-adjusted Dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1The Queens Centre for Oncology & Hematology, Hull, UK, 2Kent Oncology Centre, Maidstone Hospital, UK, 3Diana Princess of Wales Hospital, Grimsby, UK, 4St Bartholomews Hospital,, London, UK, 5Royal Lancaster Infirmary, UK, 6St. Georges Hospital Medical School, London, UK
Unplanned hospital admissions as an early surrogate indicator of patient (pt) attrition in phase I trials
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
The Institute of Cancer Research, London, UK
A novel role for Nutlin-3 in the mammalian DNA-damage response
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
St George's Hospital, University of London, UK
A two stage multicentre phase II study of Imatinib in the treatment of patients with c-kit positive metastatic uvEal Melanoma (ITEM)
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Clatterbridge Centre for Oncology, Merseyside, UK, 2Royal Liverpool University Hospital, UK, 3Liverpool Clinical Trials Unit, UK, 4Mount Vernon Hospital, Middlesex, UK, 5Weston Park Hospital, Sheffield, UK, 6St James University Hospital, Leeds, UK
Development of an oral health related quality of life module: a presentation of phase I of three in the EORTC module development process
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Oslo University Hospital, Trondheim, Norway, 2University of Leeds, UK, 3University of Athens, Greece, 4University of Freiburg, Germany, 5Institut Curie, Paris, France, 6VU University Medical Centre, Amsterdam, Netherlands, 7University of Oslo, Norway, 8Oslo University Hospital, Norway
Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals perspectives
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1The Royal Marsden NHS Foundation Trust, London, UK, 2The College of New Jersey Sociology and Anthropology, New Jersey, USA, 3The Royal Melbourne Hospital, Melbourne, Australia, 4The Institute of Cancer Research, Surrey, UK, 5The Institute of Cancer Research; The Royal Marsden NHS Foundation Trust, Surrey, UK
Translation and validation of Social Difficulties Inventory (SDI-21) into Urdu, Punjabi and Hindi
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Leeds, UK, 2Institute for Health Research, Bradford Royal Infirmary, UK, 3University of York, UK
CAPP2 long term follow up: aspirin protects against hereditary cancer
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Newcastle University, UK, 2University of Copenhagen, Denmark, 3St Marys Hospital, Manchester, UK, 4University of Southampton, UK, 5Karolinska Hospital, Stockholm, Sweden, 6The Royal Melbourne Hospital, Melbourne, Australia, 7Birmingham Women's Hospital, UK, 8Jyvskyl Central Hospital, Finland, 9St. Josefs-Hospital Bochum-Linden, Germany, 10Institut Paoli Calmettes, Marseille, France, 11University of Cape Town, South Africa, 12Foundation for Detection of Hereditary Tumours, Leiden, Netherlands, 13Leiden University Medical Center, Netherlands, 14University of Leeds, UK, 15Creighton University School of Medicine, Omaha, USA
Small intestinal atypical carcinoid tumour with clear cell features: a case report and its differential diagnosis
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
Philippine Heart Center, Quezon City, Philippines
Sensitisation of human colon cancer cell lines to TRAIL induced-apoptosis following inhibition of PI3K or HSP90
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
The Institute of Cancer Research, Sutton, UK
Peripheral Neuropathy (PN) during and 12 months after Capecitabine and Oxaliplatin chemotherapy (CAPOX) for colorectal cancer
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Edinburgh Cancer Research Centre, UK, 2Edinburgh Cancer Centre, UK
CD24 expression enhances cell migration and invasion and confers possible stem cell features in colorectal cancer lines
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
School of Molecular Medical Sciences, Nottingham, UK
Randomised phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University Hospital Ghent, Belgium, 2Queen Elizabeth Hospital, Woodville, Australia, 3Uzhgorod National University, Ukraine, 4Hospital Clinico Universitario, Valencia, Spain, 5Institut Gustave Roussy, Villejuif, France, 6Hpital Piti-Salptrire, Paris, France, 7Vanderbilt University Medical Center, Tennessee, USA, 8Nationales Centrum fr Tumourerkrankungen, Heidelberg, Germany, 9Amgen Inc, California, USA
Randomised phase 3 study of panitumumab with FOLFOX compared to FOLFOX alone as 1st line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Beatson Cancer Centre, Glasgow, UK, 2Centre Ren Gauducheau, Nantes, France, 3Ospedale Niguarda Ca Granda, Milan, Italy, 4Vall d'Hebrn University Hospital, Barcelona, Spain, 5Mount Sinai Hospital, Toronto, Canada, 6Hospital de Gastroenterologa, Buenos Aires, Argentina, 7Centre du Cancer de l'Universit Catholique de Louvain, Brussels, Belgium, 8The Royal Marsden NHS Foundation Trust, London, UK, 9Amgen Inc, California, USA
Choice of randomisation time-point in non-inferiority studies of reduced treatment duration: experience from the SCOT study
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Glasgow, UK, 2University of Oxford, UK, 3Southampton University Hospitals NHS Trust, UK
Lifestyle intervention improves exercise capacity and symptoms of fatigue in bowel cancer survivors: pilot RCT
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1Sheffield Hallam University, UK, 2Northern General Hospital, UK, 3University of Birmingham, UK
Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK Dietary Cohort Consortium
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University of Oxford, UK, 2University of Cambridge, UK, 3Guy's Hospital, London, UK, 4University College London, UK, 5University of Leeds, UK
The synthesis of novel G-quadruplex ligands and Host-Guest binding evaluation using DOSY NMR
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
Kingston University, Kingston-Upon-Thames, UK
Interferon producing killer dendritic cells (IKDC) migrate into tumours and cross present antigens in vitro and in vivo
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session
1University College London Institute of Child Health, London, UK, 2National Institute of Medical Research, London, UK, 3Great Ormond Street Hospital, London, UK
Molecular dissection of blood vessel growth and maturation during angiogenesis
Year: 2009
Session type: Poster / e-Poster / Silent Theatre session